Financing, Equity Capital Markets

Deciphera Pharmaceuticals, Inc.

02/20
|
$201.3 Million
Piper Sandler served as bookrunner for Deciphera Pharmaceuticals, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma